Genetic heart conditions and COVID-19: Podcasts, Q&As, and More

"Knowledge is the antidote to fear." - Ralph Waldo Emerson
We at Mayo Clinic's Windland Smith Rice Genetic Heart Rhythm Clinic are committed to helping our patients and their families navigate the COVID-19 pandemic and how it relates to their genetic heart disorder. The more you know about COVID-19 and its potential treatments, the more protected you and your family will be. Over the past few weeks, Dr. Ackerman has been involved in various ways to advocate for our patients with genetic heart disorders ranging from question-and-answer sessions in collaboration with the SADS Foundation to various TV and newspaper interviews discussing the role of QT monitoring for patients requiring some of the potential drugs to treat COVID-19. The most recent interviews are available below. These links, and more, are available under "What Dr. Ackerman is saying" under the COVID-19 tab.

Dr. Michael J. Ackerman & Dr. Arthur Wilde discuss COVID-19 and SADS Conditions

Q&A with Dr. Ackerman and CEO of SADS Alice Lara

COVID-19 Miniseries Episode 10: How to Mitigate Drug-induced Sudden Cardiac Death From Hydroxychloroquine (Mayo Clinic Talks Podcast featuring Dr. Michael Ackerman and hosted by Dr. Darryl Chutka)

Mayo Clinic Radio program: Dr. Abinash Virk, a Mayo Clinic infectious diseases specialist, Caroline Poland, a licensed mental health counselor, Dr. Michael Ackerman, a Mayo Clinic genetic cardiologist, and Dr. Joseph Sirven, a Mayo Clinic neurologist share the latest information on the COVID-19 (coronavirus) pandemic.